Jeffrey E. Settleman
12Patents
5h-index
22Co-inventors
66Inventor score
Filing activity: Aug 9, 1994 → Apr 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7294468B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 165 | Expired |
| US8105769B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 91 | Active |
| US7964349B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 87 | Active |
| US8465916B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 81 | Active |
| US9035036B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 5 | Active |
| US5639651A | Gap-related gene, human IQGAP1 | Chemistry; Metallurgy | 2 | Expired |
| US10596162B2 | Method for treating gefitinib resistant cancer | Human Necessities | 2 | Active |
| US10603314B2 | Method for treating gefitinib resistant cancer | Human Necessities | 2 | Expired |
| US10000815B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 0 | Active |
| US10669589B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 0 | Active |
| US12006555B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 0 | Active |
| US10953013B2 | Biomarkers of response to NAE inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.